Literature DB >> 18648141

Splenic infarction. A rare presentation of anaplastic pancreatic carcinoma and a review of the literature.

Manzhi Wong1, Ju-Yaw See, Wajiha Sufyan, Ravishankar K Diddapur.   

Abstract

CONTEXT: Anaplastic carcinoma of the pancreas is a rare variant of ductal adenocarcinoma. The histogenesis and biologic behavior of these tumors are still controversial. They occur in elderly men and are associated with a very poor prognosis. CASE REPORT: We report a case of advanced anaplastic carcinoma in a 41-year-old man who presented with splenic infarction. He had a prolonged survival of 16 months from diagnosis.
CONCLUSION: Splenic infarction is a most unusual acute presentation of pancreatic carcinoma, which may require emergency tumor resection and splenectomy.

Entities:  

Mesh:

Year:  2008        PMID: 18648141

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  5 in total

1.  Pancreatic Mucinous Cystadenocarcinoma Presenting with Splenic Infarction in a Young Female.

Authors:  Shoaib Ahmad; Sian Chisholm; John Maple
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  Anaplastic adenocarcinoma of the pancreas.

Authors:  Nickos Michalopoulos; Styliani Laskou; Yiorgos Papadakis; Georgia Karayannopoulou; Ioannis Kanellos
Journal:  J Gastrointest Cancer       Date:  2015-03

Review 3.  Cross-sectional imaging of acute abdominal conditions in the oncologic patient.

Authors:  Matthew T Heller; Vineet Khanna
Journal:  Emerg Radiol       Date:  2011-06-24

4.  Chronic Splenic Abscess as the First Manifestation of Pancreatic Tail Tumor.

Authors:  Vui Heng Chong; Muhd Syafiq Abdullah; S Sangkarakumar; Varkey Vallikad Mathew; Pemasari Upali Telisinghe
Journal:  Indian J Surg       Date:  2014-07-08       Impact factor: 0.656

5.  Anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor: a case report.

Authors:  Atsushi Nakajima; Hirokazu Takahashi; Masahiko Inamori; Yasunobu Abe; Noritoshi Kobayashi; Kensuke Kubota; Shoji Yamanaka
Journal:  J Med Case Rep       Date:  2008-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.